Lantern Pharma Inc.
SEC 4 · Filed
0001493152-25-028759Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Dec 18, 2025
Grant, award or other acquisition by Margrave David R.
- Security
- Stock Option (Right to Buy)
- Shares
-
20,000
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2025-12-18",
"direction": "A",
"exercise_price": "3.24",
"expiration": "2035-12-17",
"footnotes": {
"F1": "The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing January 18, 2026."
},
"owners": [
{
"cik": "0001813162",
"name": "Margrave David R.",
"roles": [
"officer"
],
"title": "Chief Financial Officer"
}
],
"ownership": "D",
"post_shares": "20000",
"price": "0.00",
"row": 1,
"rule_10b5_1": "0",
"security": "Stock Option (Right to Buy)",
"shares": "20000",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "20000"
}